Nurse Practitioner · Agawam, MA
NPI
1437525409
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
230 Main St
Agawam, MA, 01001
Phone (413) 789-6800
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
227 services
Medicare patients, 2024
114
Average age 70
Drug cost, 2024
$2.5M
1,013 prescriptions
Company payments, 2023
$71.93
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Beth Markens was code 99214 (office e&m - established), 59 times for 48 patients. In total Beth Markens billed 227 services in 20 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 59 | 48 | $66.44 | $3,920 |
| 99232 Hospital E&M - Subsequent | Facility | 36 | 23 | $50.78 | $1,828 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 28 | $10.37 | $322 |
| 99215 Office E&M - Established | Office | 21 | 19 | $106.92 | $2,245 |
| 99443 Telephone Services | Office | 18 | 12 | $65.47 | $1,179 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $80.89 | $1,132 |
By year: 2022 $20K for 228 services; 2023 $30K for 424 services; 2024 $14K for 227 services.
Medicare prescription drug claims, 2024
In 2024, the drug Beth Markens prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 281 prescriptions and refills. In total Beth Markens wrote 1,013 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 281 | 289 | 30 | $1.2M |
| Tivicay Dolutegravir Sodium | 82 | 88 | Under 11 | $223K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 82 | 82 | Under 11 | $312K |
| Descovy Emtricitabine/Tenofov Alafenam | 81 | 87 | 11 | $198K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 39 | 39 | Under 11 | $153K |
| Abacavir Abacavir Sulfate | 34 | 42 | Under 11 | $3,149 |
| Vemlidy Tenofovir Alafenamide | 25 | 25 | Under 11 | $44K |
| Fosfomycin Tromethamine Generic | 22 | 22 | Under 11 | $4,739 |
| Methenamine Hippurate Generic | 20 | 34 | Under 11 | $1,213 |
| Fluoxetine Hcl Generic | 19 | 19 | Under 11 | $186 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 18 | 18 | Under 11 | $120 |
| Vancomycin Hcl Generic | 16 | 22 | Under 11 | $2,113 |
| Juluca Dolutegravir/Rilpivirine | 16 | 16 | Under 11 | $55K |
| Dovato Dolutegravir Sodium/Lamivudine | 14 | 14 | Under 11 | $40K |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 14 | 24 | Under 11 | $25K |
Brand drugs: 698 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Beth Markens $71.93 ($71.93 in general payments such as food, travel and fees) from 1 company. The largest payer was Shionogi Inc with $71.93.
| Company | Payments | Amount |
|---|---|---|
| Shionogi Inc 4507.T | 1 | $71.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.